Lumentum delivered a strong Q4, beating revenue and EPS estimates, driven by robust cloud and AI demand. Read why I upgraded ...

Discover key insights from CAE Inc.'s Q1 2026 earnings call, including net debt reduction plans, Defense growth, and Civil segment challenges.

Guidance for FY2025 EPS remained unchanged at $1.22 to $1.27, consistent with the previous quarter. Management shifted the timing of some capital investments, especially the Franklin County expansion, ...

Applied Materials, reportedly, was sued by Beijing E-Town Semiconductor Technology in China over alleged trade secret theft.

Walsh provided third quarter guidance of gross originations growth in the range of 25% to 30%, revenue growth of 20% to 25%, and adjusted EBITDA between $3 million and $3.5 million. For full year 2025 ...

Collins projected growth in the number of events at venues year-over-year for fiscal 2026, with anticipated increases in concerts, including a return to growth at the Garden. Revenue growth for the ...

Reed's reported net sales of $9.5 million for Q2 2025, down from $11.9 million in the year-ago quarter. Gross profit for the quarter was $0.8 million, with gross margin at 8%, impacted by a $1.6 ...

Management maintained a confident and optimistic tone in both prepared remarks and Q&A. Lowenthal used phrases such as "we are confident," "we have a lot of flexibility," and "I believe we're well ...

CAVA Group, Inc. stock dips 24%, but long-term growth potential remains strong. Click for my look at CAVA Q2 earnings and why ...

Discover why Malaysia-focused ETF EWM may rally, with stabilizing GDP, supportive policies, valuation discounts, and bullish ...

For 2Q25, Macquarie Core Equity Fund Institutional Class shares outperformed the Fund's benchmark, the S&P 500 Index.

Recursion Pharmaceuticals (NASDAQ:RXRX) is a TechBio using its Recursion OS platform, which leverages AI to aid drug ...